Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$1.1B
Avg Funding
$44.2M
Global Reach
6
countries

Top Cities for Biopharma

Dallas
Hiroshima
Cincinnati
Milwaukee
Philadelphia
Madison

Recently Funded Companies

Export
Dallas, United States

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

$4.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Hiroshima, Japan

Purmx Therapeutics is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.

Sep 2026

Founder Contacts

41,000+ verified contacts

Cincinnati, United States

Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.

$12.9M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Dallas, United States

ClearSight Therapeutics is a biotech firm focusing on creating pharmaceutical and medical device solutions for ophthalmology.

$307K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Milwaukee, United States

N-Zyme Biomedical develops pepsin inhibitor therapies and drug formulations for reflux diseases such as LPR and GERD.

$2.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Peptaris develops AI-driven platforms for discovering and designing therapeutic peptides.

$250K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Madison, United States

Axio BioPharma is a biotechnology and biomanufacturing company that provides biologics development for biopharmaceutical production.

$2.4M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Madison, United States

Stem Pharm's synthetic biomaterials support the optimization of cell expansion.

$2.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Staten Island, United States

GevRx Nutraceuticals is a biotechnology company currently operating in stealth mode.

$300K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Geleen, The Netherlands

Matisse Pharmaceuticals is a biopharmaceutical company developing therapies for sepsis and septic shock by targeting cytotoxic histones.

$16.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Gainesville, United States

Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding.

$22.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Dijon, France

AbTx is a biotech firm developing next-generation antibody-drug conjugates with enzymatic precision for oncology.

$1.9M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Mississauga, Canada

Launch Bioindustries is a biotechnology firm that develops sustainable biomaterials using fermentation technology.

$646K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Ann Arbor, United States

Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, a condition that can affect tissues surrounding the eyes.

$123.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

$10.4M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Emeryville, United States

RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.

$44.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Phoenix, United States

Datavant protects, connects, and delivers the world’s health data to power better decisions and advance human health.

$40.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology.

$5.2M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence.

$3.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Framingham, United States

Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.

$78.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

$27.1M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.

$225.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

New Haven, United States

Cloverleaf Bio develops an RNA therapeutic platform for oncology.

$33.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

$380.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

$70.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$44.2M
Total Funding Tracked
$1.1B
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Dallas
2 companies$4.3M
2.Madison
2 companies$4.9M
3.Hiroshima
1 companiesUndisclosed
4.Cincinnati
1 companies$12.9M
5.Milwaukee
1 companies$2.8M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked